Search for: "Dependable Drugs, Inc." Results 541 - 560 of 1,050
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Sep 2013, 6:00 am by Daniel E. Cummins
The below article of mine recently appeared in the Pennsylvania Law Weekly and is republished here with permission from the publisher ALM, Inc. [read post]
27 Sep 2013, 6:00 am by Daniel E. Cummins
The below article of mine recently appeared in the Pennsylvania Law Weekly and is republished here with permission from the publisher ALM, Inc. [read post]
20 Sep 2013, 6:11 am by Lisa Baird
Under the Privacy Rule, determining whether a communication falls within the refill reminder exception depends on (1) whether the communication is about a currently prescribed drug or biologic, and (2) whether the communication involves financial remuneration and, if it does, whether the financial remuneration is reasonably related to the covered entity’s cost of making the communication. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
12 Sep 2013, 7:37 am by Bexis
  Both Mensing and Bartlett were 5-4 decisions, and therefore dependent upon Justice Thomas’ vote to make the majority. [read post]
7 Sep 2013, 12:35 pm by Lorene Park
Common law claims are also a significant risk depending on how employers respond to suspected drug use. [read post]
30 Aug 2013, 10:11 am by Tom Lamb
The Drug Safety Monitor blog from AdverseEvents has a good article about this recent Neurolgy journal article about Depacon / Depakene / Depakote / Stavzor, "New Findings Demonstrate Specific Valproate Birth Defects Dependent on Dose Strength", and we give them a so-called "hat-tip" for drawing our attention to it. [read post]
26 Aug 2013, 11:11 am
Altria Group Inc., owner of No. 1 Philip Morris USA, has the MarkTen e-cigarette, but won’t divulge its marketing plan. [read post]
21 Aug 2013, 6:52 pm by Cynthia Marcotte Stamer
Employers are not required to provide a separate notice to dependents or other individuals who are or may become eligible for coverage under the plan but who are not employees. [read post]
30 Jul 2013, 2:01 pm by Bexis
Lexis 1688, at *36) to Merrell Dow Pharmaceuticals, Inc. v. [read post]
24 Jul 2013, 5:07 am by Steve McConnell
Draeger Safety Diagnostics, Inc., Civil Action No. 13-2439 (JLL) (D. [read post]
23 Jul 2013, 12:38 pm by Ken White
Drug makers needed activists to push drugs while the CDC needed sick men. [read post]
25 Jun 2013, 9:51 am by Sheppard Mullin
Subsequently, Actavis, Inc. and Paddock Laboratories filed separate Abbreviated New Drug Applications pursuant to the Hatch-Waxman Act (21 U.S.C. [read post]
25 Jun 2013, 6:52 am
Back in 1999, Solvay Pharmaceuticals had filed a New Drug Application for a drug named AndroGel. [read post]
24 Jun 2013, 5:25 pm by Cicely Wilson
State-law design-defect claims based on the adequacy of a drug’s warnings are preempted by federal law under a 2011 Supreme Court decision, PLIVA, Inc. v. [read post]